Newsfeeds - Spark Newswire

1 minute read

Legal
News

Novan Granted U.S. Patent Titled ‘Compositions, systems, kits, and methods for treating an infection’

Today, 4:45 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6183&f=G&l=50&d=PTXT&p=124&S1=20211109&OS=20211109&RS=20211109

NOVN

1 minute read

Novan Announces Preclinical Safety Data And Intent To Advance SB019 For Treatment Of COVID-19

By Benzinga Newsdesk

Today, 4:45 PM

– Data indicate that intranasal administration of SB019 formulation containing berdazimer sodium is well-tolerated and safe under the conditions of preclinical study – – Company believes the promising

NOVN

1 minute read

News

Novan Tweets ‘We are dedicated to moving our SB019 program forward. ‘

By Benzinga Newsdesk

Today, 4:45 PM

https://twitter.com/Novan_Biotech/status/1453050379067928578

NOVN

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 4:45 PM

Gainers

AGRX

2 minute read

Earnings

How Good Are Novan’s Earnings? | Return On Capital Employed

By Benzinga Insights

Today, 4:45 PM

According to Benzinga Pro data, during Q2, Novan (NASDAQ:NOVN) posted sales of $747.00 thousand. Earnings were up 14.85%, but Novan still reported an overall loss of $7.05 million.

NOVN